on-pharmacological treatment of constipatio

Phase 2

• Conditions: constipation.; Constipation; K59.0

• Registration Number: IRCT20200601047621N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Having functional constipation based on Rome III criteria
Free and informed written consent to participate in the study

Exclusion Criteria

Any history of chronic inflammatory disease or structural disease of the gastrointestinal tract
Any serious physical problems or illness such as inflammation or malignancy
Any physical problem that prevents from doing physical activity
Drug or sleeping pills addiction
History of chronic diseases such as diabetes

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Functional constipation. Timepoint: Weeks 2, 4, 8 and 12 after the intervention begins. Method of measurement: Questionnaire for constipation.